Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients-Reference-Cited by-同舟云学术

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

Published:2019-12-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hahn Deirdre¹,Hodson Elisabeth M²,Hamiwka Lorraine A³,Lee Vincent WS⁴⁵,Chapman Jeremy R⁶,Craig Jonathan C²⁷,Webster Angela C⁵⁸

Affiliation:

1. The Children's Hospital at Westmead; Department of Nephrology; Locked Bag 4001 Westmead NSW Australia 2145

2. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145

3. University of Calgary/Alberta Children's Hospital; Department of Medicine/Pediatrics; 2888 Shaganappi Trail NW Children's Hospital Calgary Alberta Canada T3B 6A8

4. Westmead & Blacktown Hospitals; Department of Renal Medicine; Darcy Rd Westmead NSW Australia 2145

5. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead Australia

6. Westmead Millennium Institute, The University of Sydney at Westmead; Centre for Transplant and Renal Research; Darcy Rd Westmead NSW Australia 2145

7. Flinders University; College of Medicine and Public Health; Adelaide SA Australia 5001

8. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004290.pub3/epdf/full

Reference668 articles.

1. Comparison of efficacy and safety of sirolimus (SLR) and mycophenolate mofetil (MMF) as adjunct to calcineurin inhibitor (CNI) based steroid free immunosuppression in kidney transplantation [abstract no: 1530];Anil Kumar;American Journal of Transplantation,2004

2. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy;Anil Kumar;Transplantation,2005

3. A prospective randomized study to compare the efficacy and safety of sirolimus (SLR) and mycophenolate mofetil (MMF) monitored by protocol biopsies in tacrolimus (TAC) based steroid free immunosuppression [abstract no: 212];Anil Kumar;American Journal of Transplantation,2004

4. Comparison of tacrolimus (FK506) and sirolimus (SRL) combination with FK506 and mycophenolate mofetil (MMF) in kidney transplant recipients with steroid avoidance [abstract no: 771];Kumar;American Journal of Transplantation,2003

5. Comparison of four different steroid avoidance protocols in kidney transplantation: tacrolimus (TAC)/mycophenolate mofetil (MMF) versus Tac/sirolimus (SLR) versus cyclosporine (CSA)/MMF versus CSA/SLR [abstract no: 512];Anil Kumar;American Journal of Transplantation,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients;Frontiers in Medicine;2023-12-01

2. Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease‐induced neuropathological comorbidities;British Journal of Pharmacology;2023-11-15

3. Preventing Rejection of the Kidney Transplant;Journal of Clinical Medicine;2023-09-13

4. Use of everolimus following kidney transplantation during pregnancy: A case report and systematic review;Taiwanese Journal of Obstetrics and Gynecology;2023-09

5. DRESS syndrome in a patient undergoing stem cell transplantation: Can sirolimus be involved?;Clinical Case Reports;2023-09